Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Przeglad Lekarski|May 24, 2000
Flow cytometric assessment of bone marrow transplant patientI Auer, J Luider
Laboratory Hematology : Official Publication of the International Society for Laboratory Hematology|July 1, 2004
Impact of the new Beckman Coulter Cytomics FC 500 5-color flow cytometer on a regional flow cytometry clinical laboratory serviceJ Luider, M Cyfra, P Johnson, et al.
Cancer|February 19, 2000
Bone marrow staging of patients with non-Hodgkin lymphoma by flow cytometry: correlation with morphologyP R Duggan, D Easton, J Luider, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 30, 2000
Laser capture microdissection-guided fluorescence in situ hybridization and flow cytometric cell cycle analysis of purified nuclei from paraffin sectionsL M DiFrancesco, S K Murthy, J Luider, et al.
Bone Marrow Transplantation|January 1, 1995
Collection of progenitor cells for allogeneic transplantation from peripheral blood of normal donorsJ A Russell, J Luider, M Weaver, et al.
Journal of Hematotherapy|March 4, 1998
Factors influencing yields of progenitor cells for allogeneic transplantation: optimization of G-CSF dose, day of collection, and duration of leukapheresisJ Luider, C Brown, S Selinger, et al.
Bone Marrow Transplantation|July 15, 2003
Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT)R Syme, D Stewart, M Rodriguez-Galvez, et al.
Hematology (Amsterdam, Netherlands)|July 16, 2016
A Low CD34+ Cell Dose Predicts Relapse and Death Early following Autologous Blood Stem Cell TransplantationD A Stewart, D Guo, J Luider, et al.
Bone Marrow Transplantation|July 22, 1999
Factors predicting engraftment of autologous blood stem cells: CD34+ subsets inferior to the total CD34+ cell doseD A Stewart, D Guo, J Luider, et al.
Bone Marrow Transplantation|March 21, 2000
The CD34+90+ cell dose does not predict early engraftment of autologous blood stem cells as well as the total CD34+ cell doseD A Stewart, D Guo, J Luider, et al.
Pageof 2